Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Humanizing Glycosylation Pathways in Eukaryotic Expression Systems Publisher Pubmed



Khan AH1 ; Bayat H2, 3 ; Rajabibazl M4, 5 ; Sabri S6 ; Rahimpour A2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Medical Nano-Technology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), Serdang, 43400, Selangor, Malaysia

Source: World Journal of Microbiology and Biotechnology Published:2017


Abstract

Glycosylation represents the most widespread posttranslational modifications, found in a broad spectrum of natural and therapeutic recombinant proteins. It highly affects bioactivity, site-specificity, stability, solubility, immunogenicity, and serum half-life of glycoproteins. Numerous expression hosts including yeasts, insect cells, transgenic plants, and mammalian cells have been explored for synthesizing therapeutic glycoproteins. However, glycosylation profile of eukaryotic expression systems differs from human. Glycosylation strategies have been proposed for humanizing the glycosylation pathways in expression hosts which is the main theme of this review. Besides, we also highlighted the glycosylation potential of protozoan parasites by emphasizing on the mammalian-like glycosylation potential of Leishmania tarentolae known as Leishmania expression system. © 2016, Springer Science+Business Media Dordrecht.
Related Docs
View other Related Docs
1. Purification and Characterization of Recombinant Darbepoetin Alfa From Leishmania Tarentolae, Molecular Biotechnology (2016)
2. Yeast Expression Systems: Overview and Recent Advances, Molecular Biotechnology (2019)
3. Crispr-Interceded Cho Cell Line Development Approaches, Biotechnology and Bioengineering (2023)
4. Cloning and Expression of Human Bone Morphogenetic Protein-2 Gene in Leishmania Tarentolae, Biocatalysis and Agricultural Biotechnology (2016)
5. Vector and Cell Line Engineering Technologies Toward Recombinant Protein Expression in Mammalian Cell Lines, Applied Biochemistry and Biotechnology (2018)
6. Preparation of Transgenic Iranian Lizard Leishmania Coding Hil-12, Iranian Journal of Microbiology (2017)
7. Stable Expression of Anti-Cd52 Monoclonal Antibody Using a Bicistronic Vector System, Biology and Medicine (2016)
8. Application of Immuno-Pcr Assay for the Detection of Serum Ige Specific to Bermuda Allergen, Molecular and Cellular Probes (2017)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Khorramizadeh (2)
Esmaeil Sadroddiny (2)
Other Related Docs
9. Factors Involved in the Immunogenicity of Biopharmaceutical Products and Mitigation Strategies, Minerva Biotechnology and Biomolecular Research (2023)